Outcomes of second-line therapies in patients with metastatic de novo small cell prostate cancer (SCPC) and treatment-emergent neuroendocrine prostate cancer (tNEPC).

被引：0
|
作者：
Eule, Corbin
Hu, Junxiao
Al-Saadi, Sulaiman
Collier, Katharine
Boland, Patrick James
Mckay, Rana R.
Narayan, Vivek
Bosse, Dominick
Mortazavi, Amir
Rose, Tracy L.
Lam, Elaine T.
机构：
[1] Univ Colorado, Canc Ctr, Aurora, CO USA
[2] Univ Colorado, Canc Ctr, Biostat Core, Aurora, CO USA
[3] Ottawa Hosp, Canc Ctr, Ottawa, ON, Canada
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[6] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
[7] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17022
引用
收藏
页码：E17022 / E17022
页数：1
相关论文
共 50 条
  • [21] Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
    Aggarwal, Rahul
    Huang, Jiaoti
    Alumkal, Joshi J.
    Zhang, Li
    Feng, Felix Y.
    Thomas, George V.
    Weinstein, Alana S.
    Friedl, Verena
    Zhang, Can
    Witte, Owen N.
    Lloyd, Paul
    Gleave, Martin
    Evans, Christopher P.
    Youngren, Jack
    Beer, Tomasz M.
    Rettig, Matthew
    Wong, Christopher K.
    True, Lawrence
    Foye, Adam
    Playdle, Denise
    Ryan, Charles J.
    Lara, Primo
    Chi, Kim N.
    Uzunangelov, Vlado
    Sokolov, Artem
    Newton, Yulia
    Beltran, Himisha
    Demichelis, Francesca
    Rubin, Mark A.
    Stuart, Joshua M.
    Small, Eric J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) : 2492 - +
  • [22] Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 117 - 124
  • [23] Cytoreductive treatment strategies for de novo metastatic prostate cancer
    Connor, Martin J.
    Shah, Taimur T.
    Horan, Gail
    Bevan, Charlotte L.
    Winkler, Mathias
    Ahmed, Hashim U.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (03) : 168 - 182
  • [24] Cytoreductive treatment strategies for de novo metastatic prostate cancer
    Martin J. Connor
    Taimur T. Shah
    Gail Horan
    Charlotte L. Bevan
    Mathias Winkler
    Hashim U. Ahmed
    Nature Reviews Clinical Oncology, 2020, 17 : 168 - 182
  • [25] Diagnostik des Therapie-assoziierten, kleinzellig neuroendokrinen Prostatakarzinoms mittels Tumorbiopsie im metastasierten ProstatakarzinomDiagnosis of treatment-emergent small-cell neuroendocrine prostate cancer by tumor biopsy in metastatic prostate cancer
    Jost von Hardenberg
    Der Urologe, 2019, 58 (2): : 175 - 177
  • [26] Patterns of second-line chemotherapy for metastatic prostate cancer in the United States
    Wang, Hongwei
    Liao, Laura
    Obi-Tabot, Eliot
    Sands, Robert
    Rose, Mathieu
    Zhang, Quanwu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Second-Line Therapy in metastatic castration refractory Prostate Cancer (mCRPC)
    Rexer, H.
    Graefen, M.
    Merseburger, A.
    UROLOGE, 2019, 58 (03): : 359 - 360
  • [28] Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer
    Chu, Carissa
    Alshalalfa, Mohammed
    Sjostrom, Martin
    Zhao, Shuang
    Herlemann, Annika
    Chou, Jonathan
    Baskin, Avi Lefridge
    Mahal, Brandon Arvin Virgil
    Spratt, Daniel Eidelberg
    Cooperberg, Matthew R.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    Wong, Anthony C.
    Porten, Sima P.
    Hope, Thomas
    Nguyen, Paul L.
    Schaeffer, Edward M.
    Carroll, Peter
    Feng, Felix Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.
    Aggarwal, Rahul Raj
    Lloyd, Paul
    Huang, Jiaoti
    Beer, Tomasz M.
    Zhang, Li
    Thomas, George V.
    True, Lawrence D.
    Alumkal, Joshi J.
    Friedl, Verena
    Weinstein, Alana
    Reiter, Robert Evan
    Rettig, Matthew
    Lara, Primo
    Gleave, Martin
    Foye, Adam
    Playdle, Denise
    Feng, Felix Y.
    Chi, Kim N.
    Stuart, Josh
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Editorial Comment from Dr Kato to A case of metastatic treatment-emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation by liver biopsy
    Kato, Manabu
    IJU CASE REPORTS, 2022, 5 (06) : 436 - 437
12345